NNM Securities

COMPANY
more from company profile
HomeMarket Info Company Profile Smart Quotes

Smart Quotes

SOLARA ACTIVE PHARMA SCIENCES LTD.

NSE : SOLARABSE : 541540ISIN CODE : INE624Z01016Industry : Pharmaceuticals & DrugsHouse : Private
BSE541.65-20.05 (-3.57 %)
PREV CLOSE ( ) 561.70
OPEN PRICE ( ) 561.40
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 15435
TODAY'S LOW / HIGH ( )539.10 563.20
52 WK LOW / HIGH ( )287 606.95
NSE542.35-18.45 (-3.29 %)
PREV CLOSE( ) 560.80
OPEN PRICE ( ) 562.05
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 542.35 (142)
VOLUME 200663
TODAY'S LOW / HIGH( ) 535.25 564.00
52 WK LOW / HIGH ( )286 606.4
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 23-02 2017
Management Info
- Chairman Poorvank Purohit - Managing Director
Registered Office

Address 201, Devavrata,Sector 17,Vashi,
Navi Mumbai,
Maharashtra-400703

Phone 022 2789 2924 / 2789 3199

Email investors@solara.co.in

Website www.solara.co.in

Registrars Details
Cameo Corporate Services Ltd
Subramanian Buildings No 1 ,Club House Road,,Chennai
 Listing : BSE, NSE
NEWS
26Apr Solara Active Pharma Sciences sells 10
Solara Active Pharma Sciences has completed sale of 100% shareholding in..
22Apr Clarification sought from Solara Acti
The Exchange has sought clarification from Solara Active Pharma Sciences..
26Mar Solara Active Pharma Sciences gets nod
Solara Active Pharma Sciences has received approval from board of direct..
08Mar Solara Active Pharma Sciences informs
Pursuant to Section 110 of the Companies Act, 2013 read with the Compani..
08Mar Solara Active Pharma Sciences informs
Solara Active Pharma Sciences has informed that the Board in its meeting..
MORE
Financials
Rs. in Millions
QTR Dec 23 ANNUAL 23
Net Profit-2753.3-222.099999999999
Gross Profit -2753.3 -447.799999999999
Operating Profit -1612.31561.8
Net Sales 2487.314438.1
MORE
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Divi's Lab (BSE)
 4025.35 (4.81%)
M.Cap (Rs. in Cr)106860.39
Sanofi India (BSE)
 8278.10 (1.76%)
M.Cap (Rs. in Cr)19064.98
Abbott India (BSE)
 25864.85 (0.54%)
M.Cap (Rs. in Cr)54961.00
Astrazeneca Pharma I (BSE)
 5415.40 (2.18%)
M.Cap (Rs. in Cr)13538.50
Glaxosmithkline Phar (BSE)
 2132.75 (3.26%)
M.Cap (Rs. in Cr)36130.07
MORE
Shareholding Pattern
NON-INSTITUTION 50.74%
PROMOTERS 30.49%
MUTUAL FUNDS/UTI 1.71%
FI/BANKS/INSURANCE 0.04%
GOVERNMENT 0%
FII 0%
MORE
Mf Holdings
MORE
ATTENTION INVESTORSKYCIPO
TERMS & CONDITIONS| PRIVACY POLICY| REFUND & CANCELLATION POLICY| DISCLAIMER| DISCLOSURE| KMP DETAILS | CDSL e-Voting | SEBI| FMC| NSE| BSE| MCX | SCORES
Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do’s & Don’t’s) in Vernacular Language :
Assamese Bengali Gujrati Hindi Kanada
Kashmiri Konkani Malyalam Marathi Oriya
Punjabi Sindhi Tamil Telegu Urdu
REGISTRATION NOS.

NSE CM-INZ000234235|NSE F& O - INZ000234235, NSE CD-INZ000234235, BSE CM–INZ000234235 |BSE F & O - INZ000234235|BSE CD- INZ000234235 MCX-SX CM-INZ000234235|MCX-SX F & O - INZ000234235|MCX-SX CD-INZ000234235 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912,CDSL : IN-DP-242-2016|SEBI-PMS: INP000007100|LEI- 3358007DLCFNHY8J2F96

Filing compliant on SCORES – Easy & quick

  • Register on SCORES portal
  • Mandatory details for filing complaints on SCORES:
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • Benefits:
    • i.) Effective communication
    • ii.) Speedy redressal of the grievances
SMART ODR Portal
INVESTOR PROTECTION

Compliance officer : Apurva Mittal, Tel No: 022-40790035,022-40790024, Mobile No: 9152943075, E-mail ID: compliance@nnmsecurities.com, cdsl@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

"NNM Securities has partnered with TradingView for its charting technology. An investment and trading platform empowering users with global market data and analytical tools like Stock Screener and Economic Calendar."

Copyright © 2021 NNM Securities.com

Advanced Charts Technology Partner: TradingView

Designed , Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.